Galimberti, Federica

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M. (2022) · European Journal of Preventive Cardiology

Dementia and Cognitive Impairment ResearchLipoproteins and Cardiovascular Health

Cited by 197

Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: Do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials

Casula, M., Olmastroni, E., Gazzotti, M., Galimberti, F., Zambon, A., & Catapano, A. L. (2020) · Pharmacological Research

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 54

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry

D’Erasmo, L., Tramontano, D., Di Costanzo, A., Casula, M., Galimberti, F., Baratta, F., Cefalù, A. B., Tarugi, P. M., Calandra, S., Zambon, A., et al. (2025) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 9

Effects of fibrates on lipid profile: a meta-analysis of randomized controlled trials

Olmastroni, E., Galimberti, F., Xie, S., Casula, M., & Catapano, A. L. (2025) · European Atherosclerosis Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 4

Effect of angiopoietin-like protein 3 inhibitors on lipid profile and other biomarkers: a meta-analysis of randomized controlled trials

Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2026) · European Journal of Preventive Cardiology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 0